Insider Selling: UiPath (NYSE:PATH) Insider Sells $413,910.00 in Stock

UiPath, Inc. (NYSE:PATH – Get Free Report) insider Raghavendra Malpani sold 29,565 shares of the company’s stock in a transaction on Thursday, October 22nd. The shares were sold at an average price of $14.00, for a total transaction of $413,910.00. Following the completion of the sale, the insider directly owned 1,484,716 shares in the company, valued at approximately $20,786,024. The trade was a 1.95% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Raghavendra Malpani also recently made the following trade(s):

  • On Friday, October 9th, Raghavendra Malpani sold 29,564 shares of UiPath stock. The stock was sold at an average price of $13.51, for a total value of $399,409.64.
  • On Thursday, September 17th, Raghavendra Malpani sold 40,464 shares of UiPath stock. The shares were sold at an average price of $14.00, for a total value of $566,496.00.

UiPath Stock Performance

NYSE PATH opened at $14.18 on Thursday. The stock has a 50-day simple moving average of $14.39 and a two-hundred day simple moving average of $12.46. The firm has a market capitalization of $7.39 billion, a P/E ratio of 21.17, a PEG ratio of 1.33 and a beta of 1.01. UiPath, Inc. has a fifty-two week low of $9.20 and a fifty-two week high of $19.84.

UiPath (NYSE:PATH – Get Free Report) last issued its quarterly earnings data on Thursday, September 3rd. The company reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. The business had revenue of $410.26 million during the quarter, compared to analysts’ expectations of $397.77 million. UiPath had a return on equity of 9.70% and a net margin of 21.03%. The company’s revenue for the quarter was up 13.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.15 EPS. As a group, analysts forecast that UiPath, Inc. will post 0.49 earnings per share for the current year.

Hedge Funds Weigh In On UiPath

Hedge funds have recently bought and sold shares of the business. Pasadena Private Wealth LLC lifted its stake in UiPath by 9.0% in the 1st quarter. Pasadena Private Wealth LLC now owns 12,750 shares of the company’s stock valued at $142,000 after buying an additional 1,050 shares in the last quarter. CoreCap Advisors LLC increased its stake in UiPath by 68.7% during the 3rd quarter. CoreCap Advisors LLC now owns 2,679 shares of the company’s stock worth $34,000 after buying an additional 1,091 shares in the last quarter. Fifth Third Wealth Advisors LLC increased its stake in UiPath by 8.4% during the 3rd quarter. Fifth Third Wealth Advisors LLC now owns 14,174 shares of the company’s stock worth $182,000 after buying an additional 1,094 shares in the last quarter. Allworth Financial LP raised its holdings in shares of UiPath by 5.2% during the second quarter. Allworth Financial LP now owns 23,537 shares of the company’s stock valued at $256,000 after acquiring an additional 1,160 shares during the last quarter. Finally, Signaturefd LLC raised its holdings in shares of UiPath by 23.1% during the third quarter. Signaturefd LLC now owns 7,565 shares of the company’s stock valued at $97,000 after acquiring an additional 1,422 shares during the last quarter. Hedge funds and other institutional investors own 62.50% of the company’s stock.

Analysts Set New Price Targets

PATH has been the topic of several recent research reports. BMO Capital Markets lowered their price objective on UiPath from $18.00 to $15.00 and set a “market perform” rating on the stock in a research report on Thursday, September 24th. Truist Financial cut their target price on shares of UiPath from $17.00 to $14.00 and set a “hold” rating for the company in a report on Wednesday, September 23rd. Royal Bank Of Canada reiterated an “outperform” rating on shares of UiPath in a research note on Wednesday, September 23rd. HC Wainwright reiterated a “buy” rating on shares of UiPath in a research note on Friday, September 4th. Finally, Barclays increased their price target on shares of UiPath from $14.00 to $17.00 and gave the stock an “equal weight” rating in a report on Friday, September 4th. Four equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, UiPath presently has a consensus rating of “Hold” and a consensus target price of $15.69.

Check Out Our Latest Stock Analysis on UiPath

UiPath Company Profile

(Get Free Report)

UiPath, Inc develops enterprise automation software that helps organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation with artificial intelligence, workflow orchestration, process mining, document processing and application integration capabilities.

The company’s products are designed to support the discovery, development, deployment and management of software robots and AI-powered automations across functions such as finance, customer service, human resources, information technology and operations.

Featured Articles

Insider Buying and Selling by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.